Pretax income is the income that a company earns before paying income taxes. China Healthwise Holdings's pretax income for the
six
months ended in Dec. 2023 was HK$-102.8 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-132.1 Mil.
China Healthwise Holdings's pretax margin was -156.97%.
During the past 13 years, China Healthwise Holdings's highest Pretax Margin was 4.35%. The lowest was -90.26%. And the median was -33.18%.
China Healthwise Holdings Pre-Tax Income Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of China Healthwise Holdings's Pre-Tax Income
For the Pharmaceutical Retailers subindustry, China Healthwise Holdings's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Healthwise Holdings's Pre-Tax Income Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, China Healthwise Holdings's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where China Healthwise Holdings's Pre-Tax Income falls into.
China Healthwise Holdings Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
China Healthwise Holdings's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-132.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Healthwise Holdings (HKSE:00348) Pre-Tax Income Explanation
China Healthwise Holdings's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
During the past 13 years, China Healthwise Holdings's highest Pretax Margin was 4.35%. The lowest was -90.26%. And the median was -33.18%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Healthwise Holdings Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of China Healthwise Holdings's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
China Healthwise Holdings (HKSE:00348) Business Description
China Healthwise Holdings Ltd is an investment holding company. It operates in three segments: Chinese health products, Money lending business, and investment in financial instruments. The majority of its revenue comes from trading in Chinese health products, which include pharmaceutical products, ginseng, and dried seafood products. The company's geographical segments are Hong Kong and the PRC, of which key revenue is derived from Hong Kong.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:00348 has been successfully added to your 